Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-04-19

Clinical Trial Update: Observational Study to Evaluate the Safety and Efficacy for Levacalm Tab. Versus Valsartan/Amlodipine Combination Therapy in Essential Hypertension Patients

View source ↗

Summary

Observational clinical trial update evaluating safety and efficacy of Levacalm Tab. versus Valsartan/amlodipine combination for essential hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levacalm Tab. (Levacalm)
  • Valsartan/amlodipine (Valsartan/amlodipine)

Snippet

Sponsor: LG Life Sciences | Conditions: Lower Leg Edema, Orthostatic Hypertension | Status: UNKNOWN